Sponsors: []Modifications:      26-4-10.5.(1)  If a medical examiner determines that the death of a person who is 12 years of ageor older at the time of death resulted from poisoning or overdose involving a prescribedcontrolled substance, the medical examiner shall, within three business days after the day onwhich the medical examiner determines the cause of death, send a written report to theDivision of Occupational and Professional Licensing, created in Section 58-1-103, thatincludes:(a)  the decedent's name;(b)  each drug or other substance found in the decedent's system that may havecontributed to the poisoning or overdose, if known; and(c)  the name of each person the medical examiner has reason to believe may haveprescribed a controlled substance described in Subsection (1)(b) to the decedent.(2)  This section does not create a new cause of action.The division shall take the actions described inSubsection (2):(a)  a medical examiner under Section 26-4-10.5 regarding a death caused by poisoningor overdose involving a prescribed controlled substance; or(b).(2)  Theain Subsection (1)(2)medical examiner under Section 26-4-10.5 orthe(3)(2)or othersor othersor others(4)Full text:



1     REPORTING DEATH INVOLVING CONTROLLED2     SUBSTANCE AMENDMENTS3     2016 GENERAL SESSION4     STATE OF UTAH5     Chief Sponsor:  Brad M. Daw6     Senate Sponsor:   Curtis S. Bramble7      8     LONG TITLE9     General Description:10          This bill provides for the notification of a practitioner when the medical examiner11     determines that a death resulted from poisoning or overdose involving a controlled12     substance that the practitioner may have prescribed to the decedent.13     Highlighted Provisions:14          This bill:15                requires the medical examiner to provide a report to the Division of Occupational16     and Professional Licensing (DOPL) when the medical examiner determines that a17     death resulted from poisoning or overdose involving a prescribed controlled18     substance;19                requires that, when DOPL receives a report described in the preceding paragraph,20     DOPL shall notify each practitioner who may have written a prescription for the21     controlled substance involved in the poisoning or overdose; and22                makes technical changes.23     Money Appropriated in this Bill:24          None25     Other Special Clauses:26          None27     Utah Code Sections Affected:28     AMENDS:29          58-37f-702, as enacted by Laws of Utah 2010, Chapter 290 and renumbered and30     amended by Coordination Clause, Laws of Utah 2010, Chapter 29031     ENACTS:32          26-4-10.5, Utah Code Annotated 195333      34     Be it enacted by the Legislature of the state of Utah:35          Section 1.  Section 26-4-10.5 is enacted to read:36          26-4-10.5. Medical examiner to report death caused by prescribed controlled37     substance poisoning or overdose.38          (1)  If a medical examiner determines that the death of a person who is 12 years of age39     or older at the time of death resulted from poisoning or overdose involving a prescribed40     controlled substance, the medical examiner shall, within three business days after the day on41     which the medical examiner determines the cause of death, send a written report to the42     Division of Occupational and Professional Licensing, created in Section 58-1-103, that43     includes:44          (a)  the decedent's name;45          (b)  each drug or other substance found in the decedent's system that may have46     contributed to the poisoning or overdose, if known; and47          (c)  the name of each person the medical examiner has reason to believe may have48     prescribed a controlled substance described in Subsection (1)(b) to the decedent.49          (2)  This section does not create a new cause of action.50          Section 2.  Section 58-37f-702 is amended to read:51          58-37f-702. Reporting prescribed controlled substance poisoning or overdose to a52     practitioner.53          (1)  [Beginning on July 1, 2012,] The division shall take the actions described in54     Subsection (2) if the division receives a report from:55          (a)  a medical examiner under Section 26-4-10.5 regarding a death caused by poisoning56     or overdose involving a prescribed controlled substance; or57          (b)  a general acute hospital under Section 26-21-26[,] regarding admission to a general58     acute hospital for poisoning or overdose involving a prescribed controlled substance[, the].59          (2)  The division shall, within three business days after the day on which [the] a report60     in Subsection (1) is received:61          (a)  attempt to identify, through the database, each practitioner who may have62     prescribed the controlled substance to the patient; and63          (b)  provide each practitioner identified under Subsection [(1)] (2)(a) with:64          (i)  a copy of the report provided by the medical examiner under Section 26-4-10.5 or65     the general acute hospital under Section 26-21-26; and66          (ii)  the information obtained from the database that led the division to determine that67     the practitioner receiving the information may have prescribed the controlled substance to the68     person named in the report.69          [(2)] (3)  It is the intent of the Legislature that the information provided under70     Subsection [(1)] (2)(b) is provided for the purpose of assisting the practitioner in:71          (a)  discussing with the patient or others issues relating to the poisoning or overdose;72          (b)  advising the patient or others of measures that may be taken to avoid a future73     poisoning or overdose; and74          (c)  making decisions regarding future prescriptions written for the patient or others.75          [(3)] (4)  Beginning on July 1, 2010, the division shall, in accordance with Section76     63J-1-504, increase the licensing fee described in Subsection 58-37-6(1)(b) to pay the startup77     and ongoing costs of the division for complying with the requirements of this section.Legislative Review NoteOffice of Legislative Research and General Counsel

